Efficacy and Safety of OnabotulinumtoxinA for Idiopathic Overactive Bladder: A Double-Blind, Placebo Controlled, Randomized, Dose Ranging Trial-Reference-Cited by-同舟云学术

Efficacy and Safety of OnabotulinumtoxinA for Idiopathic Overactive Bladder: A Double-Blind, Placebo Controlled, Randomized, Dose Ranging Trial

Published:2010-12 Issue:6 Volume:184 Page:2416-2422
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Dmochowski Roger¹,Chapple Christopher²,Nitti Victor W.³,Chancellor Michael⁴,Everaert Karel⁵,Thompson Catherine⁶,Daniell Grace⁷,Zhou Jihao⁷⁸,Haag-Molkenteller Cornelia⁷

Affiliation:

1. Department of Urology, Vanderbilt University, Nashville, Tennessee

2. Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom

3. New York University School of Medicine, New York, New York

4. Department of Urology, William Beaumont Hospital, Royal Oak, Michigan

5. Ghent University, Flanders, Belgium

6. Allergan Ltd, Marlow, United Kingdom

7. Allergan, Inc., Irvine, California

8. Indiana University School of Medicine, Indianapolis, Indiana

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference24 articles.

1. The standardisation of terminology in lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society;Abrams;Urology,2003

2. Reviewing the ICS 2002 terminology report: the ongoing debate;Abrams;Neurourol Urodyn,2009

3. The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey;Coyne;Value Health,2004

4. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study;Coyne;BJU Int,2008

Cited by 342 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The sensory system is a target for pharmaceutical therapy of overactive bladder;Continence;2024-09

2. Botulinum toxin therapy in urology: historical aspect;Urology reports (St. - Petersburg);2024-08-08

3. Adverse Effects of Intravesical OnabotulinumtoxinA Injection in Patients with Idiopathic Overactive Bladder or Neurogenic Detrusor Overactivity: A Systematic Review and Meta-Analysis of Randomized Controlled Studies;Toxins;2024-08-05

4. Results of a study examining the use of onabotulinumtoxinA in pediatric patients with overactive bladder;Journal of Pediatric Urology;2024-08

5. Botulinumtoxin A bei idiopathischer Blasenüberaktivität (iOAB) der Frau;Die Urologie;2024-06-26